Name: UMIN ID:
Unique ID issued by UMIN | C000000073 |
---|---|
Receipt number | R000000120 |
Scientific Title | Phase2 Study of Glivec (imatinib mesylate, formerly known as STI571) in Patients with Relapsed or Refractory Sarcomas with c-kit or PDGFR Expression |
Date of disclosure of the study information | 2005/08/22 |
Last modified on | 2012/03/26 12:10:41 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2005/08/22 17:00:20 | ||
2 | Update | 2006/03/07 18:58:23 | Key exclusion criteria Key exclusion criteria |
|
3 | Update | 2006/09/29 11:56:05 | Recruitment status |
|
4 | Update | 2007/03/05 20:38:33 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
5 | Update | 2007/03/05 20:39:35 | Email1 |
|
6 | Update | 2008/08/19 16:52:19 | UMIN ID1 |
|
7 | Update | 2008/08/19 16:59:43 | Name of person sending information Name of person sending information Division name Division name TEL |
|
8 | Update | 2012/03/26 12:10:41 | URL releasing protocol Publication of results Results |